AbbVie (ABBV) Times Interest Earned (2012 - 2026)
AbbVie (ABBV) posted quarterly Times Interest Earned of $5.56 for Q1 2026, up 4.35% year-over-year from $5.33 in Q1 2025, and down 12.56% quarter-over-quarter from $6.36 in Q4 2025.
AbbVie (ABBV) Times Interest Earned (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Times Interest Earned for 15 consecutive years, with $5.56 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 4.35% year-over-year to $5.56; the TTM figure through Mar 2026 stood at $5.27 (up 49.14% YoY), while the FY2025 annual figure was $1.0, up 62.85% from the prior year.
- Times Interest Earned slipped to $5.56 in Q1 2026 per ABBV's latest filing, from $6.36 in the prior quarter.
- Across five years, Times Interest Earned topped out at $8.61 in Q1 2022 and bottomed at -$2.11 in Q4 2024.
- Historically, Times Interest Earned has averaged $5.37 across 5 years, with a median of $5.56 in 2026.
- Annual changes were most pronounced in 2024 — Times Interest Earned slumped 137.31% — and 2025, when it soared 401.12%.
- AbbVie's Times Interest Earned stood at $6.24 in 2022, then decreased by 9.19% to $5.66 in 2023, then plunged by 137.31% to -$2.11 in 2024, then soared by 401.12% to $6.36 in 2025, then slipped by 12.56% to $5.56 in 2026.
- Business Quant data shows ABBV's Times Interest Earned at $5.56 in Q1 2026, $6.36 in Q4 2025, and $2.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -2.64 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -50.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.62 |
| Mar 31, 2026 | 5.56 |
| Dec 31, 2025 | 6.36 |
| Sep 30, 2025 | 2.58 |
| Jun 30, 2025 | 6.61 |
| Mar 31, 2025 | 5.33 |
| Dec 31, 2024 | -2.11 |
| Sep 30, 2024 | 5.32 |
| Jun 30, 2024 | 5.51 |
| Mar 31, 2024 | 4.24 |
| Dec 31, 2023 | 5.66 |
| Sep 30, 2023 | 4.11 |
| Jun 30, 2023 | 8.18 |
| Mar 31, 2023 | 5.01 |
| Dec 31, 2022 | 6.24 |
| Sep 30, 2022 | 8.22 |
| Jun 30, 2022 | 5.93 |
| Mar 31, 2022 | 8.61 |
| Dec 31, 2021 | 8.75 |
| Sep 30, 2021 | 7.22 |